tetramethylpyrazine has been researched along with Protein Aggregation, Pathological in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Deng, X; Du, H; Huang, H; Kuang, X; Ling, X; Long, C; Shen, H; Shi, K; Tang, H; Wang, L; Wang, R; Xing, Y; Yan, J; Zhang, H; Zhu, X; Zou, Y | 1 |
1 other study(ies) available for tetramethylpyrazine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
2,3,5,6-Tetramethylpyrazine protects retinal photoreceptors against endoplasmic reticulum stress by modulating ATF4-mediated inhibition of PRP aggregation.
Topics: Activating Transcription Factor 4; Animals; Cell Line, Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Electroretinography; Endoplasmic Reticulum Stress; Eye Proteins; Fasting; Female; Glucose; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Prion Proteins; Protein Aggregates; Protein Aggregation, Pathological; Pyrazines; Retina; Retinal Cone Photoreceptor Cells; Retinal Degeneration; Single-Blind Method; Solubility; Specific Pathogen-Free Organisms; Transcription, Genetic | 2021 |